# Neoadjuvant Breast Cancer Time Restricted Eating

> **NCT05327608** · NA · RECRUITING · sponsor: **Thomas Jefferson University** · enrollment: 55 (estimated)

## Conditions studied

- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Breast Ductal Carcinoma in Situ
- HER2 Negative Breast Carcinoma
- Hormone Receptor Positive Breast Carcinoma
- Invasive Breast Carcinoma

## Interventions

- **OTHER:** Time Restricted Eating

## Key facts

- **NCT ID:** NCT05327608
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-28
- **Primary completion:** 2027-05-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05327608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05327608, "Neoadjuvant Breast Cancer Time Restricted Eating". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05327608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*